Somewhat Positive News Coverage Somewhat Unlikely to Impact Inovalis Real Estate Investment Trust (INO) Stock Price

News articles about Inovalis Real Estate Investment Trust (NASDAQ:INO) have trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Inovalis Real Estate Investment Trust earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave headlines about the company an impact score of 46.9999281018903 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the news headlines that may have effected Accern Sentiment’s analysis:

INO has been the subject of several research reports. HC Wainwright reissued a “buy” rating and issued a $13.00 price objective on shares of Inovalis Real Estate Investment Trust in a research report on Thursday. ValuEngine cut shares of Inovalis Real Estate Investment Trust from a “sell” rating to a “strong sell” rating in a research report on Thursday. Maxim Group reissued a “buy” rating and issued a $12.00 price objective on shares of Inovalis Real Estate Investment Trust in a research report on Tuesday, September 12th. Finally, BidaskClub raised shares of Inovalis Real Estate Investment Trust from a “sell” rating to a “hold” rating in a research report on Saturday, September 9th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company. Inovalis Real Estate Investment Trust currently has a consensus rating of “Hold” and an average price target of C$19.16.

Inovalis Real Estate Investment Trust (INO) traded up C$0.31 during trading hours on Friday, hitting C$4.74. 1,970,000 shares of the stock traded hands, compared to its average volume of 1,180,000. Inovalis Real Estate Investment Trust has a twelve month low of C$4.40 and a twelve month high of C$9.86.

Inovalis Real Estate Investment Trust (NASDAQ:INO) last posted its quarterly earnings data on Wednesday, November 8th. The company reported C($0.40) EPS for the quarter, missing the consensus estimate of C($0.25) by C($0.15). The firm had revenue of C$2.60 million for the quarter, compared to the consensus estimate of C$10.27 million. Inovalis Real Estate Investment Trust had a negative return on equity of 33.16% and a negative net margin of 46.44%. The company’s revenue was down 79.2% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.28) EPS.

The company also recently disclosed a monthly dividend, which was paid on Monday, October 16th. Investors of record on Friday, September 29th were paid a dividend of $0.069 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.83 annualized dividend and a dividend yield of 17.47%.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Inovalis Real Estate Investment Trust (INO) Stock Price” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/11/11/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-inovalis-real-estate-investment-trust-ino-stock-price.html.

Inovalis Real Estate Investment Trust Company Profile

Inovio Pharmaceuticals, Inc (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company’s DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases.

Insider Buying and Selling by Quarter for Inovalis Real Estate Investment Trust (NASDAQ:INO)

Receive News & Ratings for Inovalis Real Estate Investment Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalis Real Estate Investment Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply